lysergic acid has been researched along with oxidopamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sket, D; Sprah, L; Zivin, M | 1 |
| Glavan, G; Sket, D; Zivin, M | 1 |
2 other study(ies) available for lysergic acid and oxidopamine
| Article | Year |
|---|---|
The D1 receptor-mediated effects of the ergoline derivative LEK-8829 in rats with unilateral 6-hydroxydopamine lesions.
Topics: Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Benzazepines; Dose-Response Relationship, Drug; Genes, fos; Haloperidol; Lysergic Acid; Male; Oxidopamine; Pindolol; Rats; Rats, Wistar; Receptors, Dopamine D1 | 1996 |
Modulation of neuroleptic activity of 9,10-didehydro-N-methyl-(2-propynyl)-6-methyl-8-aminomethylergoline bimaleinate (LEK-8829) by D1 intrinsic activity in hemi-parkinsonian rats.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Benzazepines; Corpus Striatum; Disease Models, Animal; Drug Interactions; Female; Gene Expression; Lysergic Acid; Neurotensin; Oxidopamine; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D1; RNA, Messenger; Tyrosine 3-Monooxygenase | 2002 |